Haiyan Pharmaceutical Technology is a little R&D fish in the biggest sea
SHANGHAI – It is no secret that China is heavy on generics and light on innovation. But what happens when a successful drug maker with deep pockets and a visionary chairman decide to take on drug discovery? Haiyan Pharmaceutical Technology Co. Ltd., the drug development subsidiary of the Yangtze River Pharmaceutical Group (YRP), and its team of executive returnees are set to prove that innovation can be implanted anywhere, even in a risk adverse generics maker.
Outside of the US
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST